Top Page
Oxford Instruments
(LSE:OXIG)
Oxford Instruments (OXIG) vs. iShares MSCI United Kingdom ETF (EWC)
Oxford Instruments Business Overview & Revenue Model
Oxford Instruments Earnings Call Summary
Oxford Instruments Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 500.60M | 500.60M | 470.40M | 444.70M | 367.30M | 318.50M |
| Gross Profit | 253.20M | 258.80M | 242.40M | 219.50M | 176.40M | 153.90M |
| EBITDA | 56.30M | 63.10M | 93.10M | 94.80M | 67.40M | 71.60M |
| Net Income | 26.00M | 26.00M | 50.70M | 58.60M | 38.60M | 41.80M |
Balance Sheet | ||||||
| Total Assets | 604.80M | 604.80M | 606.30M | 572.00M | 514.00M | 450.70M |
| Cash, Cash Equivalents and Short-Term Investments | 94.10M | 94.10M | 97.80M | 112.70M | 96.40M | 128.00M |
| Total Debt | 40.90M | 40.90M | 47.40M | 43.90M | 28.90M | 37.90M |
| Total Liabilities | 228.70M | 228.70M | 240.60M | 228.00M | 197.60M | 184.50M |
| Stockholders Equity | 376.10M | 376.10M | 365.70M | 344.00M | 316.40M | 266.20M |
Cash Flow | ||||||
| Free Cash Flow | 35.10M | 33.20M | 14.70M | 34.70M | 34.50M | 36.70M |
| Operating Cash Flow | 49.50M | 49.10M | 42.40M | 67.60M | 49.20M | 41.80M |
| Investing Cash Flow | -27.80M | -27.40M | -37.50M | -37.50M | -45.70M | -4.90M |
| Financing Cash Flow | -18.40M | -18.40M | -18.00M | -16.60M | -15.70M | -30.50M |
Oxford Instruments Technical Analysis
Oxford Instruments Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $1.04B | 40.82 | 4.64% | 1.14% | -5.39% | -73.52% | |
69 Neutral | £2.53B | 30.13 | 9.15% | 2.12% | 3.15% | -13.57% | |
67 Neutral | £1.13B | 33.19 | 23.28% | 2.77% | 2.15% | -39.26% | |
63 Neutral | £4.08B | 70.23 | 4.26% | 2.05% | 0.07% | -78.33% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
42 Neutral | £54.35M | -1.08 | -37.55% | ― | -24.75% | -110.79% |
Oxford Instruments Corporate Events
Oxford Instruments PLC, a prominent player in the high technology sector, specializes in providing advanced scientific technology and systems for industry and research, with a focus on materials analysis, semiconductors, and healthcare & life sciences. The company recently released its interim results for the first half of the 2025/26 financial year, highlighting a challenging start due to macroeconomic disruptions but noting a return to positive momentum in the second quarter.
The recent earnings call for Oxford Instruments PLC revealed a mixed sentiment, balancing between challenges and growth opportunities. While the company faced significant disruptions in the first quarter and currency headwinds, it demonstrated resilience through strong order growth in its Advanced Technologies division, operational improvements, and a robust balance sheet. The outlook for the second half of the year remains optimistic, with expectations for strong revenue growth. However, challenges in the Imaging & Analysis division and shipment delays slightly dampen the positive sentiment.
Oxford Instruments reported its half-year results for 2025/26, revealing a recovery after initial macroeconomic disruptions in Q1. The company saw improved order momentum in Q2, particularly in its Advanced Technologies division, which experienced strong demand from US and European commercial customers. Strategic actions in Imaging & Analysis, including cost restructuring and re-pricing efforts, are expected to enhance margins in the second half. The sale of the NanoScience business is anticipated to complete in Q3, and the company has increased its share buyback program by £50m. Despite a drop in revenue and operating profit, Oxford Instruments maintains a strong balance sheet and expects improved performance in the second half, supported by new product launches and strong order books.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2039.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments plc announced that as of 31 October 2025, its issued share capital with voting rights consists of 56,618,054 ordinary shares. This figure is significant for shareholders as it serves as the denominator for calculating their interests in accordance with the UK Financial Conduct Authority’s Disclosure Guidance and Transparency Rules. This update ensures transparency and compliance with regulatory requirements, impacting how stakeholders manage their shareholdings.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2039.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments has issued a trading update for the first half of 2025, revealing a mixed performance across its divisions due to global economic uncertainties and tariff disruptions. While the Imaging and Analysis division faced challenges with a decline in order intake, the Advanced Technologies division experienced strong growth driven by the compound semiconductor market. Despite a decrease in first-half revenues, the company anticipates a stronger second half, supported by cost-saving measures and a robust order book in its Advanced Technologies division. The sale of the NanoScience business is on track, and the company remains confident in its strategic actions to navigate the dynamic market landscape.
The most recent analyst rating on (GB:OXIG) stock is a Buy with a £2114.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments reported mixed results for the first half of 2025, with its Imaging and Analysis division facing challenges due to tariffs and economic uncertainty, while the Advanced Technologies division saw strong growth driven by the compound semiconductor market. Despite a decline in overall revenue, the company expects a stronger performance in the second half of the year, supported by cost-saving measures and strategic initiatives, with full-year results anticipated to be stable on an organic constant currency basis.
The most recent analyst rating on (GB:OXIG) stock is a Buy with a £2114.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments plc has announced that as of September 30, 2025, its issued share capital with voting rights consists of 56,936,273 ordinary shares. This figure is significant for shareholders as it serves as the denominator for calculating their interests or changes in interests in compliance with the UK Financial Conduct Authority’s Disclosure Guidance and Transparency Rules. This update ensures transparency and aids stakeholders in maintaining compliance with regulatory requirements.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2017.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments has executed a share buyback program, purchasing 12,000 of its own shares at an average price of 1906.4885 pence per share. This move is part of a strategic initiative to optimize the company’s capital structure, potentially enhancing shareholder value and reflecting confidence in its financial health.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2017.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments has executed a share buyback program, purchasing 24,028 of its own ordinary shares at an average price of 1783.9481 pence per share. This move reduces the total number of shares in issue to 57,232,157, impacting the company’s voting rights and potentially influencing shareholder interests.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £1961.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments plc announced that as of 29 August 2025, its issued share capital with voting rights consists of 57,309,182 ordinary shares. This figure is important for shareholders to determine their notification requirements under the FCA’s Disclosure Guidance and Transparency Rules, impacting how they manage their shareholdings.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £1991.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments plc announced a transaction involving its Chief Executive Officer, Richard Tyson, who acquired Partnership Shares and Matching Shares under the company’s Share Incentive Plan. This transaction, conducted on the London Stock Exchange, reflects the company’s adherence to the EU Market Abuse Regulation, indicating a commitment to transparency and regulatory compliance.
The most recent analyst rating on (GB:OXIG) stock is a Buy with a £2500.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments has executed a share buyback program, purchasing 16,755 of its own ordinary shares at an average price of 1834.6167 pence per share. This transaction, conducted through Numis Securities Limited, will result in a total of 57,508,549 ordinary shares in issue, impacting the company’s share capital and potentially influencing shareholder value.
The most recent analyst rating on (GB:OXIG) stock is a Buy with a £2500.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.